Development of a Simple Noninvasive Model to Predict Significant Fibrosis in Patients with Chronic Hepatitis B: Combination of Ultrasound Elastography, Serum Biomarkers, and Individual Characteristics

被引:12
|
作者
Chen, Xin [1 ,2 ]
Wen, Huiying [1 ,2 ]
Zhang, Xinyu [1 ,2 ]
Dong, Changfeng [3 ]
Lin, Haoming [1 ,2 ]
Guo, Yanrong [1 ,2 ]
Shan, Lingbo [3 ]
Yao, Simin [3 ]
Yang, Min [3 ]
Le, Xiaohua [2 ]
Liu, Yingxia [3 ]
机构
[1] Shenzhen Univ, Sch Biomed Engn, Shenzhen, Peoples R China
[2] Guangdong Key Lab Biomed Measurements & Ultrasoun, Natl Reg Key Technol Engn Lab Med Ultrasound, Shenzhen, Peoples R China
[3] Shenzhen Third Peoples Hosp, Shenzhen Inst Hepatol, Shenzhen 518020, Peoples R China
基金
中国国家自然科学基金;
关键词
RADIATION FORCE IMPULSE; LIVER FIBROSIS; TRANSIENT ELASTOGRAPHY; INDEX; BIOPSY; ALGORITHMS; ARFI; QUANTIFICATION; REPEATABILITY; MARKERS;
D O I
10.1038/ctg.2017.11
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVES: The accurate assessment of liver fibrosis is clinically important in patients with chronic hepatitis B (CHB). Blood tests and elastography are now widely used for the noninvasive diagnosis of liver fibrosis in CHB patients. The aim of this study was to develop a new and more accurate predictive model, which combines elastography data, serum biomarkers, and individual characteristics, to discriminate between CHB patients with and without significant liver fibrosis. METHODS: Two noninvasive methods, specifically, an ultrasound elastography technique termed acoustic radiation force impulse imaging (ARFI) and a blood test, were used to assess a cohort of 345 patients (estimation group, 218 patients; validation group, 127 patients) with CHB. Multivariate logistic regression analysis revealed that ARFI, the aspartate aminotransferase (AST) to platelet ratio, and age were significantly associated with fibrosis. Based on these results, we constructed and validated a model for the diagnosis of significant hepatic fibrosis. RESULTS: The area under the receiver operating characteristic (ROC) curve was 0.921 for the estimation group and 0.929 for the validation group, significantly higher than those for ARFI (0.887, 0.893) and for the AST-to-platelet ratio index (APRI; 0.811, 0.859). Using an optimal cutoff of 3.05 in the validation group, all the indices of the proposed model, including accuracy, sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic odds ratio, were better than those for ARFI or APRI. CONCLUSIONS: We developed a simple noninvasive model that used ultrasound elastography, routine serum biomarkers, and individual characteristics to accurately differentiate significant fibrosis in patients with CHB. Compared with elastography or the biomarker index alone, this model was significantly more accurate and robust.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Noninvasive serum markers to stage fibrosis in patients with chronic hepatitis B infection
    Lu, Mei
    Lamerato, Lois
    Rupp, Loralee B.
    Holmberg, Scott D.
    Moorman, Anne C.
    Spradling, Philip R.
    Teshale, Eyasu H.
    Nakasato, Cynthia
    Boscarino, Joseph A.
    Henkle, Emily
    Nerenz, David R.
    Gordon, Stuart C.
    [J]. HEPATOLOGY, 2012, 56 : 360A - 361A
  • [22] Development and evaluation of a novel noninvasive index for predicting significant fibrosis, advanced fibrosis, and cirrhosis in patients with chronic hepatitis B infection
    Kayadibi, Huseyin
    Yilmaz, Baris
    Yeniova, Abdullah Ozgur
    Koseoglu, Huseyin
    Simsek, Zahide
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E121 - E130
  • [23] Development and evaluation of a novel noninvasive index for predicting significant fibrosis, advanced fibrosis, and cirrhosis in patients with chronic hepatitis B infection
    Kayadibi, Huseyin
    Yilmaz, Baris
    Yeniova, Abdullah Ozgur
    Koseoglu, Huseyin
    Simsek, Zahide
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E121 - E130
  • [24] Stepwise noninvasive assessment to predict significant fibrosis in chronic hepatitis B patients who do not meet definite treatment guideline
    Kim, Jin Dong
    Jung, Jin Yong
    Yim, Sun Young
    Seo, Yeon Seok
    Um, Soon Ho
    Ryu, Ho Sang
    [J]. HEPATOLOGY, 2014, 60 : 993A - 993A
  • [25] Simple noninvasive tests for the detection of advanced liver fibrosis in patients with chronic hepatitis B
    Huang, Rui
    Zhao, Xiang-An
    Wang, Jian
    Hao, Yingying
    Wu, Chao
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (02) : 241 - 241
  • [26] A Simple Noninvasive Index Can Predict Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
    Zhu, Lihui
    Li, Tao
    Ma, Xiaomin
    Qiu, Yumin
    Ma, Xiaoxiao
    Lin, Yueke
    Han, Lihui
    Qin, Chengyong
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [27] A Simple Noninvasive Index Can Predict Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
    Lihui Zhu
    Tao Li
    Xiaomin Ma
    Yumin Qiu
    Xiaoxiao Ma
    Yueke Lin
    Lihui Han
    Chengyong Qin
    [J]. Scientific Reports, 7
  • [28] Significant Fibrosis by Transient Elastography and Comparison With Non-Invasive Modalities in Patients With Chronic Hepatitis B and Chronic Hepatitis C
    Alhankawi, Dhuha
    Jacob, Ahlin
    Niknam, Negar
    Shah, Prasun
    Ayoola, Rotimi R.
    Zheng, Christina
    Park, James
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S536 - S536
  • [29] Analysis of three ultrasound elastography techniques for grading liver fibrosis in patients with chronic hepatitis B
    Xinping Ren
    Shujun Xia
    Zhongxin Ni
    Weiwei Zhan
    Jianqiao Zhou
    [J]. La radiologia medica, 2018, 123 : 735 - 741
  • [30] Analysis of three ultrasound elastography techniques for grading liver fibrosis in patients with chronic hepatitis B
    Ren, Xinping
    Xia, Shujun
    Ni, Zhongxin
    Zhan, Weiwei
    Zhou, Jianqiao
    [J]. RADIOLOGIA MEDICA, 2018, 123 (10): : 735 - 741